InvestorWire NewsRoom

Article

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians
February 12, 2021

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians

  • Bergen Neurology Consultants utilized BRSF’s devices to improve patient care
  • Minimal training means more staff can administer, monitor the EEG; more appointments can be scheduled

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, has created two devices designed to disrupt the EEG market. The NeuroCap(TM) and NeuroEEG(TM) offer cost-effective, disposable substitutes that help improve patient’s access to neurological care. The company is also helping improve the quality of care and solutions that practices can offer their patients.

An example of the impact of the device can be seen through Bergen Neurology Consultants, a premier provider of neurological care (https://ibn.fm/6BVN6). Bergen Neurology wanted to offer its patients ambulatory EEGs. The problem is that strict Medicare regulations required a routine EEG first. Bergen Neurology’s offices were not set up to provide the traditional in-office EEGs that would make the ambulatory ones “medically necessary” for the insurance companies.

The company discovered an optimal solution in the NeuroCap and NeuroEEG. Through its wholly owned subsidiary, MemoryMD Inc., BRSF was able to help Bergen Neurology Consultants streamline its practice, recoup revenue and improve patient care.

Because of their size and ease of use, the NeuroCap and NeuroEEG allowed Bergen Neurology to implement in-office EEGs within a week. One problem with traditional EEGs is that administering and monitoring requires an EEG technician. Within an hour, all of Bergen’s six medical assistants were trained in how to administer and monitor the BRSF EEG devices. Workers who typically are involved in patient scheduling and administrative duties were allocated to this vital task with minimal training.

This meant that more staff could administer the in-office EEGs allowing the practice to schedule them more often. The time it also took to use the NeuroCap and NeuroEEG decreased from one hour to 40 minutes, allowing for more tests to be scheduled. In addition, the original problem of reimbursement from insurance companies was resolved.

Brain Scientific is working hard to disrupt the EEG industry and provide solutions that make neurological care more accessible. The company’s work with Bergen Neurology is an example of how BRSF is establishing a new innovative norm for clinicians.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).